欧盟电子处方系统的比较:发展,使用和未来趋势的基准分析
IEEE journal of biomedical and health informatics
|March 4, 2025
概括
电子处方系统 (EPS) 已在欧盟成员国广泛采用,大多数国家将在2022年之前实施. 尽管技术设计相似,但在各个国家系统的功能和使用方面存在显著差异.
科学领域:
- 医疗信息学 医疗信息学
- 数字健康政策 数字健康政策
- 医疗系统比较分析与分析.
背景情况:
- 欧盟成员国对电子处方系统 (EPS) 的比较研究有限.
- 之前的研究通常集中在单个系统上,使用各种方法,缺乏当前数据.
- 需要对EPS开发,功能和采用的全面概述.
研究的目的:
- 为所有欧盟成员国提供电子处方系统 (EPS) 的全面比较分析.
- 记录国家EPS的发展,功能和使用统计数据.
- 确定EPS实施和技术解决方案中的相似之处和差异.
主要方法:
- 通过对来自欧盟各成员国的共同作者组成的跨国团队管理的结构化问卷收集数据.
- 分析到2022年EPS采用状态,技术架构,功能和使用情况.
- 对处方有效性,药物覆盖范围和认证方法的比较评估.
主要成果:
- 到2022年,在大多数欧盟成员国广泛采用EPS,但有一些例外 (例如,德国,法国,卢森堡).
- 主要的技术设计涉及一个带有最终用户软件或Web应用程序的中央服务器;27个系统中有22个是国家系统.
- 尽管技术上有相似之处,但在功能,处方有效性,药物覆盖范围和认证方面观察到显著差异.
结论:
- 对于EPS的基本技术解决方案在整个欧盟都是相似的,但在实施和功能方面仍然存在显著差异.
- 在EPS领域需要标准化研究方法.
- 综合性比较分析对于为欧盟医疗保健政策和数字健康战略提供信息至关重要.
相关概念视频
01:29Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
01:30Methods of Documentation VII: EMR
823
Electronic Medical Records (EMRs) primarily center around electronically documenting patients' health information within a single healthcare organization or practice. They contain essential clinical data related to a patient's medical history, diagnoses, medications, treatment plans, lab results, and other pertinent information relevant to the specific encounter or episode of care. EMRs are designed to streamline documentation and workflow processes within individual healthcare...
823
01:30Health Information Technology and Healthcare Information System
787
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
787
01:16Bioequivalence: Overview
907
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
907
01:02Prescription, Nonprescription and Orphan Drugs
677
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
677
01:03Drug Control Governance: Regulatory Bodies and Their Impact
135
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
135